Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 10 microgram. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Pharmacist reported that "we had a couple patients that received 10mcg dosage from the Dark Pink Cap and a Label with a Yellow Box).    No concomitant medications was reported. No treatment drug details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-723711, US-MODERNATX, INC.-MOD-2023-723709, US-MODERNATX, INC.-MOD-2023-723710, US-MODERNATX, INC.-MOD-2023-723712, US-MODERNATX, INC.-MOD-2023-723713, US-MODERNATX, INC.-MOD-2023-723714, US-MODERNATX, INC.-MOD-2023-723715, US-MODERNATX, INC.-MOD-2023-723716, US-MODERNATX, INC.-MOD-2023-723717, US-MODERNATX, INC.-MOD-2023-723718, US-MODERNATX, INC.-MOD-2023-723719, US-MODERNATX, INC.-MOD-2023-723720, US-MODERNATX, INC.-MOD-2023-723721, US-MODERNATX, INC.-MOD-2023-723722, US-MODERNATX, INC.-MOD-2023-723723, US-MODERNATX, INC.-MOD-2023-723724, US-MODERNATX, INC.-MOD-2023-723706 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723723:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723724:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723706:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723716:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723711:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723717:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723719:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723709:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723718:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723720:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723721:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723713:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723714:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723722:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723715:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723710:Patient 1(Master Case) US-MODERNATX, INC.-MOD-2023-723712:Patient 1(Master Case)